WHAT`S NEW?

In the Highlights

November 2023 Our CEO & Co-Founder Nahum Ferera on the Odelle Technology Podcast

Our CEO & Co-Founder Nahum Ferera on the Odelle Technology Podcast

Read
February 2022 Therapeutic contact lens for Fuchs endothelial corneal dystrophy: Monitoring with Scheimpflug tomography

This case report demonstrates the effectiveness of a combined unique soft contact lens design and hypertonic saline at reducing corneal edema symptoms.

Read
July 2021 EyeYon Medical 2021 Mid-year Newsletter

Read the latest news from EyeYon Medical

Read
February 2021 EndoArt Received the Breakthrough Device Designation from the FDA

Our revolutionary EndoArt® received the Breakthrough Device Designation from the FDA.

Read

News

September 2020 EyeYon Medical's Q3/20 Newsletter

Read the latest news from EyeYon Medical

Read
September 2020 A new type of corneal availability

All you wanted to know about the disruptive EndoArt Artificial Endothelial Layer (and some more….).

Read
February 2020 EndoArt® receives the Breakthrough Device Designation from the FDA

Our revolutionary EndoArt® receives the Breakthrough Device Designation from the FDA. A very meaningful milestone in the path to the market

Read

Events

October 2023 AA0 2023

We are looking forward to attending the American Academy of Ophthalmology event in San Francisco next week!

Read
September 2023 ESCRS 2023

Our CEO, Nahum Ferera is at the Ophthalmology Futures Forum at the Hilton Danube in Vienna, as part of the annual The European Society of Cataract and Refractive Surgeons (ESCRS) Congress.

Read
June 2023 DOC 2023

Our CCO, Charles Holmes, presented EndoART to the delegates at the DOC. It was great to see Prof. Dr. med. Gerd U. Auffarth, FEBO on the panel speaking highly of EndoART, marking the 4 year anniversary of the first EndoART implantation by Prof.Auffarth himself!

Read